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The word “autism” comes from “autos”, greek word 
that means “itself” or “to itself”. It is a syndrome with 
extremely variable phenotype, being considered a 
disturbance of human development.
Reports on the increase in autism prevalence in the 
population, studies concerning treatment efficacy and 
high costs in education and care of these patients has 
made this pathology a focus of great interest in public 
health.
It is estimated that the prevalence of Disturbances 
of Autism Spectrum (DASs) is 0.5-1% and seems to 
increase 15% each year. The discussion between a real 
increase of these disorders or a possible improvement 
in diagnosis, remains [1].
Autism Spectrum
History and definition
The study of autism started 7 decades ago. It was 
described for the first time in 1943 by the Austrian 
doctor Leo Kanner, in his scientific paper “Autism 
Disturbances of Affective Contact” [2]. In this work, the 
author started to group a set of apparently characteristic 
behaviours, present in eleven children followed by him, 
mainly boys. In theory, these behaviours could help to 
identify children with this disturbance, that showed 
perceived, emotional and cognitive deficit [2-4]. In the 
two following decades and despite the publication of 
that study, there was a lack of interest on this disorder.
However, first results pointed to the similarity 
between the terms Autism and Child Schizophrenia, 
that probably led to their incorrect differentiation. 
Confirming this fact, the concept of autism had already 
been introduced by Bleuler in 1911, by referring to 
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Introduction
Since the beginning of human existence, commu-
nities exclude or neglect those that deviate from nor-
mal standards at physical or mental levels. A lot comes 
from the unfounded myths and believes and from the 
unknown itself. Nowadays, interest on this population 
is increasing and consequently research is focusing on 
deepening knowledge on these disturbances aiming 
their integration on a society build apart from those 
who have special needs.
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perger syndrome) [4].
GDDs (among them are ASDs) involve a group of 
clinical changes with early onset where diverse basic 
areas of behaviour and development are simultaneously 
compromised. Rett syndrome and Disintegrative 
Disturbance of Second Childhood are also included in 
this group [5,12].
Behaviour analysis of ASDs
Although now a days knowledge concerning autism 
is much more prefound, it still surprises due to the 
diversity of characteristics that patients can show.
Usually, the autistic child has normal physical [3,13]. 
However, these children also show an irregular profile 
of development that is detectable in the first three 
years of life, being present till adulthood. The Triade 
of Social Impediments is characterized by a strict and 
continuous pattern with intelligence levels varying from 
mental retardation to an extraordinary performance in 
certain cognitive domains (like music, arts, mathematic, 
memory) or savant capacities [3,4,10,14]. Although 80% 
of autistic children show mental retardation, savant 
capacities can exist, however the global intelligence 
ratio is low [3,12,14]. The difference between mental 
retardation and autism should be pointed out: The first 
one shows a uniform development deficit; while the 
last presents an irregular profile, with differentiated 
degrees of commitment.
The following classification and diagnosis systems 
allow to distinguish autism from other disorders: 
International classification of Diseases of the World 
Health Organization and the Manual of Diagnosis 
and Statistics of Mental Disorders from the American 
Academy of Psychiatry (DSM-IV). In these systems the 
term Child Autism was replaced by Autistic Disturbance, 
officially separating it from Asperger syndrome [15].
According with Siegel [8] echolalia (child repeats 
the same sound consecutively), incapacity to play 
symbolic games, prenominal inversion (use of the third 
person instead of the first), abnormal voice sound, 
absence or deficit of speech, peculiar relation within 
animate objects, stereotyped interests, repetitive 
schizophrenia as a limitation in human relationships and 
the outside world [5]. In 1971, the two concepts were 
finally dissociated due to differences in symptoms (such 
as the age of onset of first symptoms), family history 
and differences in response to treatment of adults 
suspected to have schizophrenia/child autism [1].
After Kanner, Hans Asperger [6] published a paper 
entitled “Childhood Autistic Psychopathology”, based 
on the study of four children described as carriers of the 
same resistance in the establishment of social contact, 
and the same pattern of restrict interests, but having 
sophisticated language skills [6]. At this moment, the 
term Asperger Disturbance appeared [4,7]. Nowadays, 
it is easily distinguished from classic autism [8].
After the work of these two scientists, other 
clinical studies followed up, however, only with the 
publication of the 4th edition of the Diagnostic and 
Statistical manual of Mental Disturbances (DSM-IV), 
of the American Association of Psychiatry, autism 
was classified as a type of Global Disturbance of 
Development (GDD) [4,9]. Nowadays, it is described as 
a change in normal development of a child that shows 
abnormal “communication, socialization and restrict and 
stereotyped behaviours” [4]. Among GDDs, it is possible 
to distinguish different types: Asperger syndrome; 
Global Disturbance of non-specified Development 
(GDD-NS); Rett Syndrome and Child Disintegrative 
Disturbance [4,5,9], (Table 1).
According with Lorna Wing, the degree of autism 
varies with the deficits observed over time at social in-
teraction, verbal and non-verbal communication and 
the use of imagination, being called the “Triade of Social 
Impediments” [10]. Deviations of these disturbances re-
sult from their very heterogeneous and mostly unknown 
aetiology [11]. So, description of autistic spectrum goes 
far from strict definitions, including individuals with low 
cognitive potential that reveal deficit on reciprocal ver-
bal communication and repetitive behaviours together 
with mental retardation and those having high cognitive 
potential that even having deficit in social interaction 
with repetitive and stereotyped behaviours, do not 
show retardation in speech development (like in the As-
Table 1: Diagnosed types of GDDs according to the classification of DSM-IV-TR [5].
Global developmental disturbances Characteristics
Autistic Disturbances* Classic autismo
Rett Syndrome Genetic condition (mutations in MECP2 gene). It mainly affects girls and 
reaches post-natal brain development.
Child Disintegrative Disorder Cognitive, behavioural and speech regression of 2-10 years, preceded 
by fully normal development, and with posterior appearance of autistic 
characteristics.
Asperger Disturbance* Individuals with one autistic characteristics that develop speech in 
expected age, without mental retardation.
Global Disturbance of non-specified Development* Individuals with some autistic characteristics, but not as severe or 
extensive that do not belong to any other categories.
*Together also called Autism Spectrum Disorders (ASDs).
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those genes can be modulated by environmental factors 
from the gestational period. It should be emphasized 
that several deficiencies with cerebral involvement 
associated with ASDs, occur during the first and second 
trimester of pregnancy (teratogenic effect) [1].
Although a large study using microarray tests 
performed by Shen, et al. [19] observed that 80% 
of analysed autistic children had a normal genome, 
several other studies point for the existence of a narrow 
correlation between genetic predisposition (above 90%) 
and environmental factors [4]. Some consistent changes 
during gestation of affected individuals are known, 
however, pre-natal diagnosis is still not possible, mainly 
because no physical traits can be identified. The first 
alert sign is the deficient social interaction of the child, 
mainly observed between 6 months and 3 years of age 
[15].
In autism aetiology, “it is observed a drastic 
decrease in risk for family members of the second or 
third degree, pointing to the involvement of multiple 
interactive genes”, that influence each other [20]. 
However, although numerous investigations at the 
pharmacological, pathological, electrophysiological and 
imaging levels have been done, ASDs aetiology is still 
under discussion [21].
Diagnosis
Since it is still not possible the use of genetic 
markers for this disorder, diagnosis is usually based on 
meticulous investigation of the history of the patient 
and family inquiry (cognitive and behaviour capacities) 
according with Autism Diagnostic Interview-Revised 
(ADI-R) and the Autism Diagnostic Observation Schedule 
(ADOS) [16].
It is believed that autism appearance is related with 
some brain anomaly, not yet defined, associated with 
a genetic cause. Since ASDs show a very heterogenous 
aetiology, no definitive medical test or cure for this type 
of disorders has been developed yet. For this reason, 
only in very few cases definitive diagnosis happens 
before twenty-four months of age (a well established 
diagnosis is normally done between 3 and 6 years of 
age) [22].
In this way, evaluation should be done by one or 
more professionals with medical background and 
several years of clinical experience. The doctor tries to 
investigate, through several exams, the existence of 
disorders with known causes that can lead to a child 
autistic picture, such as the X-fragile syndrome or the 
Rett disturbance [15].
Clinical genetic tests can also be performed, and 
the usually used strategy involves, in the first place, 
a chromosome microarray analysis that allows the 
detection of chromosome copy number variation as 
well as the existence of chromosomal deletions or 
behaviours, deficit in social, emotional and interests 
share and trouble in establishing visual and physical 
contact are common characteristics of autism [8]. Other 
symptoms frequently observed in these individuals are 
hyperactivity, attention deficit, impulsivity, aggressivity 
and self-aggressivity [13].
Individuals with Asperger disturbance reveal social 
deficits and restricted interests. However, their speech 
capacities remain intact, or show speech capacities 
above average for their age [4,8].
Individuals with Global Disturbance of non-
specified Development show changes in one or more 
developmental areas, however, these are not enough 
to be included in the autistic or Asperger disturbances, 
since they are lower in number or intensity [16].
The phenotypic heterogeneity or high variability 
observed in behavioural standards and in social and 
communication capacity gave rise to the predominant 
use of the term Autistic Spectrum Disturbances [15].
The distinction between autistic disturbance and 
the remaining ASDs is more complicated due to the 
simultaneous occurrence of one or more psychiatric and 
neurological disorders in most patients (72%), including: 
Attention/hyperactivity deficit, tic disorder, dyspraxia 
(neurological motor dysfunction), dyslexia (reading, 
writing and spelling difficulty), obsessive-compulsive 
disorder, phobias, anxiety, humour, sleep and feeding 
disturbances [17].
Prevalence
In the Portuguese population, the prevalence of 
DASs is one in a thousand children [3,17]. It is estimated 
that 60-70 in 10,000 individuals suffer from a Global 
Disturbance of Development, and 20 in each 10,000 are 
disturbances of the autistic spectrum (one third being 
Asperger disturbance). These values make DASs the most 
frequent forms of child developmental disturbances, 
and a rise is being observed over the last decades [18]. 
However, prevalence differs between gender, being 
four times higher in men. Even so, an autistic female is 
usually more affected at cognitive level [3,17].
Aetiology
Since Kanner studies, some characteristic aspects 
of autism started to be analysed in the personality of 
parents and affected children. Initially, the cause of 
autism was associated with parents emotionally and 
socially cold. Later, scientific studies associated autism 
to mental retardation, genetic syndromes, epilepsy and 
other neurological conditions that had the organic bases 
of autism and related disorders [5]. These have strongly 
contributed to elucidate the biological aspects of ASDs 
and demonstrated that these are complex conditions, 
with multiple aetiologies and diverse degrees of severity. 
Although evidences demonstrate that most cases of 
ASDs result from genetic causes, the expression of 
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muscular hypotony and motor coordination problems, 
together with strong or moderate mental retardation, 
absence or delayed speech and severe hyperactivity. If 
deletions occur in the referred chromosomic regions, 
maternal or paternal, imprinting diseases will develop: 
Angelman and Prader-Willi syndromes respectively [24].
Rett syndrome
Rett syndrome associated with the MeCP2 gene, is a 
dominant disease associated with the X chromosome, 
being considered one of the factors responsible for a 
small number of autism cases. This syndrome is usually 
lethal in boys. The most frequent mutations occur in 
exons 2, 3 and 4 of the mentioned gene [14].
Epilepsy
Some researchers refer that epilepsy episodes in 
individuals diagnosed with ASDs, occur in a casual 
form. Data show an increased risk of epilepsy in ASDs 
individuals, resulting from a Central Nervous System 
anomaly characterized by neuropathological changes. 
One third of autistic individuals develop epilepsy, since 
dysfunctions in the CNS strongly increase the risk of 
developing it. The prevalence of autistic children with 
epilepsy varies between 5 and 46% [13,21].
Schizophrenia
This condition can be associated with exposure to 
infections before birth and subsequent inflammatory 
response. In the same way, autism can result from this 
phenomenon since it shares with schizophrenia several 
brain morphological changes [1].
According with Meyer et al. [1] infections in women 
during the critical periods of pregnancy can lead to 
acute inflammation associated with the presence of 
cytokinin in the foetal system, particularly at brain 
level. This affects negatively neuronal development 
processes: Proliferation, migration and cell survival. In 
this way, acute inflammation during foetal neuronal 
development can lead to the formation of abnormal 
neuronal substrates that interfere with social, cognitive 
and emotional behaviour processes, among others.
Mental retardation
The AGTR2 gene, present in the X chromosome 
(Xq22-q23), seems to be involved in the development 
of mental retardation in autistic individuals, since these 
patients show deletion of this gene. However, the 
Xq13-q21 region that contains genes of the neuroligins 
family is even more important in the development of 
this condition. Neuroligins are crucial in processes 
of cellular interaction, through adhesion molecules, 
between neuronal cells [24,25].
Approximately 75-80% of autistic children suffer a 
severe mental retardation [5].
duplications of considerable size. The second approach 
involves molecular DNA tests for specific genes or even 
whole genome sequencing. For instance, patients can 
be tested for Fragile X syndrome by the analysis of 
specific single gene or, in the presence of a specific 
feature/condition, search for a set of genes that have 
been associated with those characteristics.
Autism genesis is divided in Secondary Autism (with 
environmental agents, chromosomal anomalies or 
identified genetic changes) and in Idiopathic (without 
known cause and involving more than ten genes), being 
this last one the most common [3].
Secondary Autism: Genetic Factors
Several genetic diseases are related with an 
increased risk of ASDs, being responsible for 5-10% 
of total diagnosed cases. Since autism prevalence is 
higher in men, several studies have proposed that the 
genetic influence of the X chromosome increases the 
susceptibility for ASDs [14].
X-Fragile syndrome (XFS)
Patients usually show developmental problems, 
mainly speech and motor retardation, or even, autistic 
behaviours. Since the locus of the main involved gene 
is the X chromosome (Xq27.3), the probability of 
X-fragile syndrome development is increased in males. 
In most cases (99%), the disease is related with the loss 
of function of the FMR1 gene, that results from the 
presence of multiple copies of the triplet repeat CGG 
in the 5´ untranslated region (5´ UTR) of that gene. The 
FMR1 protein (FMR1P - fragile X mental retardation 
1 protein) is the product of the FMR1 gene, and is 
mainly present in neuron cytoplasm, being involved 
in important processes like ribosomal translation and 
maturation of synapse structure and function, having 
a suppressor effect at the post-synaptic region [14,23].
The number of CGG repeats is variable and can be 
classified as a pre-mutation (59-200 repetitions) or full 
mutation (above 200 repeats). In the presence of a 
pre-mutation transmitted by the mother, the meiotic 
instability might result in a complete mutation [14].
Autism has a high prevalence in XFS individuals, 
reaching 25-33%. The FMR1 protein can affect the 
expression of several genes involved in autism 
development. However, XFS is distinguishable from 
autism by the presence of a specific biomarker, 
the abnormal expansion of the CGG repeat in the X 
chromosome [14,23].
Down and Pradel-Willi/Angelman syndrome
Down syndrome is the most frequent cytogenetic 
anomaly in patients with ASDs (7-10% of individuals are 
carriers of ASDs), followed by the one found in the region 
15q11-13 (present in 1-4% of autistic patients). When the 
15q11-13 region suffers duplication or inversion, a high 
incidence of epilepsy in childhood is observed, as well as 
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women, shows epistatic effects (hierarchy between 
alleles) that involve an interaction between several 
genes, suggesting the role of environmental factors [32].
Genes Involved in Autism: Candidate Genes
Studies on monozygotic and dizygotic twins, adopted 
children and their families helped the establishment of 
a strong genetic component in autism. Still, analysis 
performed on the genome of autists failed in the 
establishment of consistent signs of linkage. None 
of cognitive and affective diseases, as well as certain 
psychoses, follow a heritage pattern according with 
Mendel’s laws, reinforcing the hypothesis of the 
involvement of multiple genes [24].
Since it is a complex disorder with the involvement 
of several variants, each contributing with a reduced 
risk to phenotype, the identification of susceptibility 
genes has been difficult. Moreover, hypotheses that 
support the presence of synergism and/or epistas 
is between multiple candidate genes are based on 
chromosomic changes that are not always enough for 
disease development [24]. So, traditional methods of 
linkage used in most studies, are insufficient to detect 
modest genetic effects, in typically small samples. It is 
then necessary to select candidate genes based on the 
type of coded proteins that play an important function 
in autism development [33].
A big number of involved chromosomes suffer translo-
cations and inversions. These changes result in interrup-
tion of genes as well as deletions and duplications that 
are responsible for differences in gene expression. The 
most frequently reported mutations are duplications in 
15q11-q13 and deletions in 2q37, although most of them 
are undetectable by karyotype analysis [34].
Idiopathic Autism
Idiopathic autism is the type of autism with unknown 
aetiology, representing 90-95% of total diagnosed cases. 
Several genes have been tested as possible candidates 
for its development, and, so far, more than 10 genes 
have been identified [5,11].
Genetic Bases of Autism
Several psychiatric diseases have strong evidences of 
genetic involvement in their origin, and among them are 
schizophrenia, bipolar disturbance and autism. In 1977, 
a study with mono and dizygotic twins described for the 
first time the genetic predisposition of autism [26,27].
Nowadays, population studies suggest that the 
model that better describes DASs is multifactorial 
[13,20,28,29] with a concordance of 60-92% in monozy-
gotic twins and 0-10% in dizygotic twins [30]. Differenc-
es found in studies between monozygotic twins support 
the multifactorial model, demonstrating the importance 
of environmental factors.
Several studies were performed to clarify genetic 
factors associated with the disease. Autism symptoms 
that suggest a strong genetic component are convul-
sions, mental deficiency, neurons and synapse decrease 
in amygdala, hippocampus and cerebellum, increased 
size of encephalon, and increased level of circulating 
serotonin. Even studies with monozygotic twins show a 
significant concordance, as opposed to dizygotic twins. 
Non-twin siblings present a risk of developing autism 
ranging from 0-30%, and this risk is much higher than in 
the general population [31].
The comparison of the mentioned populational 
groups, as well as the difference between men and 
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Figure 1:  Brain-related genes though to have a role on the prevalence of Autism.
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DISC1 gene (rs1322784) was also associated with male 
patients having ASDs [29].
The discovery of interaction between the TRAX and 
DISC2 genes and the DISC1 gene raised a new hypothesis 
that is based on the possibility of molecular mechanisms 
leading to brain dysfunctions at the affective and 
cognitive levels.
DYX1C1 gene
It is present in locus 15q21 and codes for a protein 
whose role is still not completely understood. However, 
it has already been established that it is expressed in 
a subgroup of human neuronal and glial cells, being 
the first candidate gene for dyslexia and the second 
associated with language disturbances. In the presence 
of genetic change, like a translocation, the gene is 
interrupted and can lead to two variants. One of these 
is related with the loss of attachment place to several 
linking factors. The second leads to the appearance of 
a premature stop codon and consequent loss of four 
amino acids at the end of the coded protein [25].
Dyslexia is a disturbance characterized by problems 
in learning to read or write (independent of the intelli-
gence degree, social extract or interests of the individ-
ual). This phenotype has some interest in the study of 
ASDs since it might represent other disturbances with 
language development delay. However, it doesn’t seem 
likely to be a very relevant gene in autism development 
[25].
ItGB3 gene
It is located in chromosome 17 (q21.3) and codes 
for β-integrin 3. This protein is present in cell surface, 
especially in platelets. Integrins are known by their 
participation in cell adhesion and in metabolism 
and neurotransmission of serotonin (5-HT). Integrin 
receptors have shown an important role in signalling, 
being able to influence transcription and translation 
[30,36].
According with Napolioni et al. [30] the presence 
of a single nucleotide polymorphism located at the 5’ 
terminal of theITGB3 gene, is strongly related with high 
plasma levels of 5-HT, one of the characteristics most 
frequently found in autists (around 30% of autistic 
individuals) [36,37]. Allelic variants of theITGB3gene 
were identified in some studies, both isolated or 
interacting with allelic variants of the gene coding for 
5-HT transporter (SLC6A4 gene, located close to the 
ITGB3 gene) [30,36].
Moreover, Schuch, et al. [38] analysed five single 
nucleotide polymorphisms in the ITGB3 gene. These 
researchers observed small association of the rs15908 
and rs12603582 polymorphisms with symptoms of 
echolalia, epilepsy and aggressivity, characteristics of 
ASDs [38].
According with Freitag [27] some chromosomic 
deletions in 2q37, 7q31, 22q11 and 22q13.3, are also 
important in the cytogenetic evaluation of autism. 
Chromosomic micro deletions responsible for certain 
syndromes, are associated with the appearance of 
secondary autism: Velocardiofacial syndrome, DiGeorge 
syndrome and Facial Conotruncal anomaly syndrome.
Several genes have been associated with the 
development of autism. However, the appearance 
of this condition seems to involve the combination 
of changes in several genes, behaving in an additive 
manner. 
In this study, brain-related genes though to have a 
role on the prevalence of this disorder are described 
(Figure 1). However, many other genes seem to play a 
role in the development of this condition, as is the case 
of genes encoding ion-channels.
AVPR1a gene
This gene is located at the long arm of chromosome 
12 and encodes the arginine-vasopressin receptor 
(AVPR). Mutations in this gene lead to changes in the 
number of these receptors. The first report on changes 
in this gene associated with ASDs dates from 2002. In 
this study, researchers genotyped two microsatellite 
polymorphisms from the 5' flanking region of the 
AVPR1a gene. This work found significant transmission 
disequilibrium between autism and one of the 
microsatellite markers. Moreover, ten single nucleotide 
polymorphisms were identified by screening 2 kb of the 
5' and coding region of the gene [35].
The CNS shows differences in receptor distribution 
that might interfere with the effects of the AVP system, 
among which are: Vocal position; sexual and parental 
behaviour; aggressivity; and social recognition. The AVP 
system reveals stronger effects in males [28].
According with Wassink et al. [28] autism 
susceptibility can increase by changes in the gene 
coding for the receptor 1a of the AVP system (AVPR1a). 
These changes lead to deficient social interaction, lack 
of parental behaviour, severe aggressivity, among other 
symptoms.
DISC1 gene
This gene is present in the locus 1q42 that contains 
the TRAX and DISC2 genes (involved in the regulation 
of DISC1 gene expression). The DISC1 gene codes for 
a protein with an essential function in growth and 
neuronal migration, in synaptogenesis, in glutamatergic 
neurotransmission (whose molecular processes of 
synaptic modification are among the most common in 
all CNS), and in cAMP signal transduction [29].
Kilpinen, et al. [29] were able to establish an associa-
tion between autism and a DISC1 intragenic microsatel-
lite (D1S2709). A single nucleotide polymorphism in the 
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Moreover, Tian [41] identified two mutations in 
the RELN gene, and the g.504742G > A polymorphism, 
present in exon60, showed a significant association with 
autism in a Chinese Han population.
Some studies reveal linkage picks in the long arm 
of chromosome 7 that contains the RELN gene, and 
other susceptibility genes for autism, namely in the 
region 7q22-q33 [24,33]. Attention should be given to 
this gene, since changes observed in cerebellar neurons 
have impact in autism development [24].
RPL10 gene
It is present in chromosome Xq28 and codes for a 
family of ribosomal L10 proteins, that participate in the 
control of gene expression and are probably involved in 
cell signalling pathways. Mutations in the RPL10 gene 
(involving amino acid replacement) allow translation 
but a premature stop of protein synthesis occurs [42].
There is a marked difference in autism prevalence 
between males and females, being men the most 
frequently affected, suggesting a possible involvement 
of the X chromosome. The existence of linkage with 
markers in Xq22.3, Xq13-q26 and Xq27-q28 has been 
demonstrated. Changes in genes present in the region 
Xq28 lead to predisposal to mental retardation, that is 
frequently associated with autism [42].
Klauck et al. [42] have identified two missense 
mutations in the RPL10 gene in two independent 
families with autism. These mutations are the amino-
acid substitutions L206M and H213Q at the C-terminal 
end of RPL10 protein that leads to changes in the 
regulation of the translation process. These researchers 
suggested as a model for the development of autistic 
disorder, that a change in translational function has 
impact on cognitive functions mediated through the 
limbic system [42].
ShANK3 gene
It is present in chromosome 22 (q13.3) and codes 
for a protein (expressed at cortex, hippo campus and 
cerebellum levels) involved in excitatory synapses 
in front of the pre-synaptic active zone, and in the 
formation of intracellular protein complexes, by the 
establishment of connexions that favour protein 
interactions [43].
Several studies refer the identification of duplications 
in the SHANK3 gene that seem to have an important 
role in autism [43]. Cases of deletion of 22q13.3 with 
interruption or removal of the SHANK3 gene have been 
described. The resultant phenotype includes delay in 
expressive language, severe mental retardation and 
autism [43].
A single nucleotide polymorphism (rs9616915) is a 
T > C change in exon 6, that leads to a substitution of 
isoleucine to threonine and directly affects SHANK3 gene 
function. Mashavekhi et al. [44] were able to associate 
Genes that influence the serotonin system are 
strong susceptibility genes, since selective drugs for the 
serotonin system reveal more efficacy in the treatment 
of some misbehaviour found in autism (like disturbances 
related with anxiety and aggression) [36].
SLC6A4 gene
This gene is in the long arm of chromosome 17 and 
codes for the serotonin transporter. This is a chemical 
substance that acts at brain level, through signal 
transmission between neurons (synapses). The role 
of serotonin system in autism is not totally clarified 
yet, however, it is known that polymorphisms of this 
gene can modulate the recapture of the transporter, 
explaining the occurrence of hyper-serotonin in some 
autistic individuals [36,39].
According with Longo [5] insertion/deletion 
polymorphisms located at the promoter of the SLC6A4 
gene have been identified. Serotonin levels in synapses 
are regulated by its transporter and, when this one 
becomes active, serotonin builds-up in blood platelets 
instead of rising in synapses (where it is low). This can 
lead to important behaviour changes that determine 
the appearance of autism [5,36].
Adamsen et al. [40] identified three heterozygous 
mutations in the SLC29A4 gene: c.86A > G (p.Asp29Gly) 
in two patients, c.412G  > A (p.Ala138Thr) in five 
patients and c.978 T  >  G (p.Asp326Glu) in one patient. 
Expression of mutations p.Ala138Thr and p.Asp326Glu 
in cells revealed significant reduced transport uptake 
of serotonin and dopamine, linking these mutations to 
ASD although with low brain serotonin. Dysfunction of 
this protein is speculated to raise serotonin prenatally, 
exerting a negative feedback inhibition through 
serotonin receptors on development of serotonin 
networks and local serotonin synthesis [40].
ReLN gene
This gene is present in locus 7q22 and codes for 
a protein with an important role in migration of 
diverse cell types and in the development of neuronal 
connexions. It is believed that the RELN gene can affect 
the development of autism [33].
According with Skaar et al. [33] one of the most im-
portant effects of the deletion of this gene in rats, is the 
abnormal formation of cerebral cortex. Moreover, the 
study of this gene revealed its importance in the cor-
rect formation of brain structures due to the orientation 
that they confer in migration of neuronal precursors. 
According with these data, the RELN gene is related 
with several neurogenetic diseases (like schizophrenia 
and bipolar disorder), that show low levels of mRNA and 
RELN protein in multiple brain areas. The following ge-
netic changes can be pointed out: Expansion of a trinu-
cleotide polymorphic repeat (GGC) and haplotypes with 
replacement of two bases of one exon [24,33].
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Neuropsychopharmacol 37: 196-212.
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idiopático. Universidade Federal do Rio Grande do Sul.
15. Oliveira G (2009) Autismo: Diagnóstico e Orientação. Parte 
I - Vigilância, Rastreio e Orientação nos cuidados primários 
de saúde. Acta Pediatr Port 40: 278-287.
16. Oliveira G, Ataíde A, Marques C, Miguel T, Coutinho AM, 
et al. (2007) Epidemiology of autism spectrum disorder in 
Portugal: Prevalence, clinical characterization and medical 
conditions. Dev Med Child Neurol 49: 726-733.
17. Oliveira G, Diogo L, Grazina M, Garcia P, Ataíde A, et 
al. (2005) Mitochondrial dysfunction in autism spectrum 
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47: 185-189.
18. Fombonne E (2009) Epidemiology of pervasive 
developmental disorders. Pediatr Res 65: 591-598.
19. Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, et 
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spectrum disorders. Pediatrics 125: E727-E735.
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this mutation to increased risk of autism development.
Conclusion
Several advances in the study of autism genetics have 
been done, leading to drastic changes in the concept of 
autism, in the last decades.
According with the complexity of disturbances of the 
autistic spectrum, the analysis of isolated genes is not 
conclusive. It is very unlikely that any study performed 
with a candidate gene, covers a high percentage 
of sample population, consequently its inclusion in 
phenotype is difficult to identify.
Nowadays, most genetic studies focus on specific 
regions of chromosomes according with the probability 
of the corresponding genes being related with the 
observed characteristics of the disease. Obtained 
knowledge on genetic or environmental factors is very 
important for correct diagnosis and treatment and may 
allow prevention of the disorder.
A lot is still to be clarified in the autism spectrum 
disturbances, since it is likely that several susceptibility 
factors are involved and some still to be discovered. It 
is urgent to identify genetic variants not yet detected 
by the conventional genotyping studies, focusing on 
simultaneous analysis of multiple loci.
Diagnosis criteria used for autistic spectrum 
disturbances, have been improved. The ideal diagnosis 
would be the identification of genetic variants 
responsible for specific autistic phenotypes.
It is undeniable the contribution of heritance in 
autism disease but without considering environmental 
factors, it becomes insufficient to explain this complex 
disease.
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